These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 20408852)

  • 1. Computational design and biological testing of highly cytotoxic colchicine ring A modifications.
    Torin Huzil J; Winter P; Johnson L; Weis AL; Bakos T; Banerjee A; Luduena RF; Damaraju S; Tuszynski JA
    Chem Biol Drug Des; 2010 Jun; 75(6):541-50. PubMed ID: 20408852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrostatic contributions to colchicine binding within tubulin isotypes.
    Huzil JT; Barakat K; Tuszynski JA
    Electromagn Biol Med; 2009; 28(4):355-64. PubMed ID: 20017626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer assisted design of second-generation colchicine derivatives.
    Huzil JT; Mane J; Tuszynski JA
    Interdiscip Sci; 2010 Jun; 2(2):169-74. PubMed ID: 20640786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitors.
    Chuang HY; Chang JY; Lai MJ; Kuo CC; Lee HY; Hsieh HP; Chen YJ; Chen LT; Pan WY; Liou JP
    ChemMedChem; 2011 Mar; 6(3):450-6. PubMed ID: 21360819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free energy calculations on the binding of colchicine and its derivatives with the alpha/beta-tubulin isoforms.
    Mane JY; Klobukowski M; Huzil JT; Tuszynski J
    J Chem Inf Model; 2008 Sep; 48(9):1824-32. PubMed ID: 18712858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel anticancer bivalent colchicine-tubulizine hybrids.
    Malysheva YB; Combes S; Allegro D; Peyrot V; Knochel P; Gavryushin AE; Fedorov AY
    Bioorg Med Chem; 2012 Jul; 20(14):4271-8. PubMed ID: 22739088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.
    Liu T; Dong X; Xue N; Wu R; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(17):6279-85. PubMed ID: 19665898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
    Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
    J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [4-(imidazol-1-yl)thiazol-2-yl]phenylamines. A novel class of highly potent colchicine site binding tubulin inhibitors: synthesis and cytotoxic activity on selected human cancer cell lines.
    Mahboobi S; Sellmer A; Höcher H; Eichhorn E; Bär T; Schmidt M; Maier T; Stadlwieser JF; Beckers TL
    J Med Chem; 2006 Sep; 49(19):5769-76. PubMed ID: 16970401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
    Bhattacharyya B; Panda D; Gupta S; Banerjee M
    Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
    Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
    Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
    J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
    Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
    J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
    Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
    J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents.
    Qian Y; Zhang HJ; Lv PC; Zhu HL
    Bioorg Med Chem; 2010 Dec; 18(23):8218-25. PubMed ID: 21036623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naphthylphenstatins as tubulin ligands: synthesis and biological evaluation.
    Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M
    Bioorg Med Chem; 2008 Oct; 16(19):8999-9008. PubMed ID: 18790642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor evaluation of nitrovinyl biphenyls: anticancer agents based on allocolchicines.
    Jain N; Yada D; Shaik TB; Vasantha G; Reddy PS; Kalivendi SV; Sreedhar B
    ChemMedChem; 2011 May; 6(5):859-68. PubMed ID: 21472861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents.
    Jiang J; Sun B; Wang YY; Cui M; Zhang L; Cui CZ; Wang YF; Liu XG; Lou HX
    Bioorg Med Chem; 2012 Apr; 20(7):2382-91. PubMed ID: 22365913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
    Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M
    J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
    Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
    Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.